Shots:
- The companies collaborated to evaluate the usability of DNA Link’s AccuFind COVID-19 IgG antibody test in a healthcare setting
- The study intends to expand access to antibody testing outside of laboratory settings
- The companies plan to launch the study in Dec’2020
Click here to read full press release/ article | Ref: PRNewswire | Image: Base 10 genetics
The post BASE10 Collaborates with DNA Link to Support Authorization of COVID-19 IgG Antibody Test at the Point of Care first appeared on PharmaShots.